Identification of Candidate Inhibitors to SARS-CoV-2’s Enzymes and Potential Disruptors of Its Structural Proteins’ Interactions

Drug repurposing is a promising approach for the rapid identification of potential treatments for emerging diseases such as coronavirus disease.

Authors

Institutions

Publication Details

Journal
Advanced Biomedical Research
Published
2025-12-01
DOI
https://doi.org/10.4103/abr.abr_138_23
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of Candidate Inhibitors to SARS-CoV-2’s Enzymes and Potential Disruptors of Its Structural Proteins’ Interactions

Aylar Imanpour, Mahdieh Jadaliha, Hamed Pourvali Moghadam, Ali Mohammadian et al.
Advanced Biomedical Research
Computational Drug Discovery Methods
article

Identification of Candidate Inhibitors to SARS-CoV-2’s Enzymes and Potential Disruptors of Its Structural Proteins’ Interactions

Aylar Imanpour, Mahdieh Jadaliha, Hamed Pourvali Moghadam, Ali Mohammadian, AmirHossein Jahangir
article en

Abstract

Drug repurposing is a promising approach for the rapid identification of potential treatments for emerging diseases such as coronavirus disease.

Advanced Biomedical ResearchVol. 14(1)
Sharif University of Technology (IR), University of Tehran (IR), Universal Scientific Education and Research Network (IR), Amol University of Special Modern Technologies (IR)
Openalex Percentile: Top 27%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.